pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Omisirge
drug
save

omidubicel

Phase 3updated 3mo ago
by Gamida Cell Ltd
Phase 3
community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying omidubicel

  • phase3Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDScompletedn=125
  • phase3Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignanciescompletedn=36
  • —Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patientscompletedn=33

News(0)

no news has mentioned this drug yet

brand
Omisirge
generic
omidubicel-onlv
indication
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
phase
phase_3
Data sources
ClinicalTrials.gov
last refreshed 12m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?